Related Experiment Video
Updated: Aug 27, 2025

Isolation of Cerebral Capillaries from Fresh Human Brain Tissue
Published on: September 12, 2018
Cerebral venous thrombosis in a young asymptomatic COVID-19 patient
Rafael Dias1,2,3, Ricardo Soares Dos Reis1,2, Sara Pereira de Sousa4
1Department of Neurology, Centro Hospitalar Universitário de São João.
Insights
Cerebral venous thrombosis (CVT) can occur with asymptomatic SARS-CoV-2 infection. This case highlights a potential link between COVID-19, CVT, and thrombocytopenia, relevant to vaccine discussions.
Area of Science:
- Neurology
- Infectious Diseases
- Hematology
Background:
- Cerebral venous thrombosis (CVT) is a rare but serious condition.
- COVID-19 (severe acute respiratory syndrome coronavirus 2) has been linked to thrombotic events.
- Most reported cases involve symptomatic COVID-19 patients.
Purpose of the Study:
- To report an unusual case of CVT associated with an asymptomatic SARS-CoV-2 infection.
- To contribute to the understanding of thrombotic complications of COVID-19.
- To explore potential parallels between COVID-19-associated CVT and vaccine-associated CVT.
Main Methods:
- Case report of a patient presenting with CVT.
- Diagnostic confirmation of past SARS-CoV-2 infection through molecular and serological testing.
- Assessment of clinical presentation, laboratory findings (including thrombocytopenia), and absence of COVID-19 symptoms.
Main Results:
- The patient experienced CVT temporally associated with an otherwise asymptomatic SARS-CoV-2 infection.
- Laboratory tests confirmed a past SARS-CoV-2 infection (>3 weeks prior).
- The patient presented with thrombocytopenia, similar to some cases of vaccine-associated CVT.
Conclusions:
- Asymptomatic SARS-CoV-2 infection can be associated with CVT.
- This case expands the spectrum of thrombotic events linked to COVID-19.
- The presence of thrombocytopenia in this case may inform discussions on COVID-19 vaccines and CVT risk.
Abstract:
We report an unusual case of cerebral venous thrombosis (CVT temporally associated with an otherwise asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. While coronavirus disease 2019 (COVID-19) has been associated with thrombotic events at different sites, most published cases report on symptomatic SARS-CoV-2 infection. We are confident this was an otherwise asymptomatic infection as the patient reported no symptoms and molecular and serological testing was consistent with infection more than 3weeks in the past. We believe this is an important report as it adds to the existing literature on thrombotic events in patients with COVID. It may even inform discussion of COVID vaccines and CVT since our patient, as those reported in association with vaccines, also had thrombocytopenia on admission.
More Related Videos
Related Concept Videos
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction
Venous Thrombosis IV: Nursing Management

